Importantly, overexpression of SOX2 in the IVL+ tumour-resistant population overrode the activation of the apoptotic programme, marked by the expression of activated cleaved CASP3 and PARP seen before in the Ivl:BRAFV600E model (Fig. 6g and Supplementary Fig. 2f). The gene discussed is SOX2; the disease is neoplasm.